August Krogh Building
Copenhagen, Denmark
NCT Number: NCT03349944
The project will investigate high intensity interval training on the glucose regulation in type 2 diabetic subjects compared to moderate continuous exercise.
Looking for future studies?
Notify Me30 year–70 year
Male
Interventional
Not applicable
Copenhagen, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Type 2 diabetes Age: 30-70 Non smokers (minimum the last 15 years) Inactive lifestyle (<2 hours pr. week) BMI <35 kg/m2
Exclusion criteria
Smoking Prior cardiavascular diseases Alcohol intake 14> units pr. week.
The duration of the training intervention is 10 weeks of either moderate exercise og high intensity interval training.
Time frame: From baseline measure to post test: 10 weeks
Long term blood glucose levels
Time frame: From baseline measure to post test: 10 weeks
75gr glucose is ingested, bllod sampling over the following two hours
Morten Hostrup, PhD
Other
Effect of High Intensity Interval Training on Nuclear Orphan Receptor Expression and Adrenergic Signaling in Skeletal Muscle of Persons With Type 2 Diabetes.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05108987
Behavior, Diabetes Mellitus
New Brunswick, New Jersey, United States
View Trial DetailsNCT03133156
Behavior, Body Weight
Boston, Massachusetts, United States
View Trial DetailsNCT03709966
Behavior, Diabetes Mellitus
Québec, Quebec, Canada
View Trial DetailsNCT03534687
Alzheimer Disease 10, Behavior
Ann Arbor, Michigan, United States
View Trial Details